Difficulty: Medium
Average Score: 82%
Practice
Which of the following neuromuscular blocking agents cause cardiac arrhythmias?
Correct answer
D
Rationale
The correct answer is D) Succinylcholine. Succinylcholine is a depolarizing neuromuscular blocking agent that can cause cardiac arrhythmias, specifically malignant hyperthermia and prolonged bradycardia, due to its mechanism of action and effects on acetylcholine receptors in the heart.
A) Vecuronium is a non-depolarizing neuromuscular blocking agent that does not typically cause cardiac arrhythmias. It acts by competitive inhibition of acetylcholine at the motor end plate.
B) Tubocurarine is another non-depolarizing neuromuscular blocking agent that does not directly cause cardiac arrhythmias. It works by blocking nicotinic acetylcholine receptors at the neuromuscular junction.
C) Rapacuronium is a non-depolarizing neuromuscular blocking agent that was actually withdrawn from the market due to its association with severe bronchospasm in some patients, not cardiac arrhythmias.
Understanding the effects of different neuromuscular blocking agents on the body is crucial for healthcare providers, especially in critical care settings where these medications are commonly used during surgeries or mechanical ventilation. Recognizing the potential adverse effects of these drugs can help prevent complications and ensure patient safety.
A) Vecuronium is a non-depolarizing neuromuscular blocking agent that does not typically cause cardiac arrhythmias. It acts by competitive inhibition of acetylcholine at the motor end plate.
B) Tubocurarine is another non-depolarizing neuromuscular blocking agent that does not directly cause cardiac arrhythmias. It works by blocking nicotinic acetylcholine receptors at the neuromuscular junction.
C) Rapacuronium is a non-depolarizing neuromuscular blocking agent that was actually withdrawn from the market due to its association with severe bronchospasm in some patients, not cardiac arrhythmias.
Understanding the effects of different neuromuscular blocking agents on the body is crucial for healthcare providers, especially in critical care settings where these medications are commonly used during surgeries or mechanical ventilation. Recognizing the potential adverse effects of these drugs can help prevent complications and ensure patient safety.